Skip to main content

Advertisement

SpringerLink
Log in

Determinants of Long-Term Outcome of Patients with Reflux-Related Ear, Nose, and Throat Symptoms

  • Esophageal, Gastric, and Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Gastroesophageal reflux disease (GERD) is present in up to 75% of patients with chronic refractory ear, nose, and throat (ENT) symptoms, and proton pump inhibitor (PPI) therapy induces symptom relief in the majority of these patients. It has been suggested that endoscopic findings and quantification of esophageal acid exposure may help to predict the long-term outcome of medical therapy, but prospective studies that confirm this hypothesis are lacking. The aim of the present study was to investigate the relationship of endoscopic findings and quantification of reflux with long-term outcome in patients with reflux-related ENT symptoms. One hundred six consecutive patients with chronic refractory unexplained ENT symptoms underwent upper GI endoscopy, 24-hr dual-channel esophageal pH and Bilitec (n = 35) monitoring, and esophageal manometry. Subsequently, all were treated with omeprazole, 20 mg b.i.d., and patients were followed at 2-week intervals until symptom relief. Four weeks later, omeprazole therapy was gradually decreased and the lowest effective omeprazole maintenance dose, if any, was determined. Eighty-one patients (49 men; mean age, 50) experienced a clear or excellent therapeutic response after, on average, 4 weeks of omeprazole, 20 mg b.i.d. In 36 patients (44%; group A), PPI treatment could be stopped completely, 27 patients (33%; group B) required a maintenance dose of omeprazole, 20 mg/day, and 18 patients (22%; group C) required maintenance with omeprazole, 40 mg/day. The prevalence of reflux esophagitis was significantly lower in group A patients, who also had significantly lower distal esophageal acid exposure, proximal esophageal acid exposure, and esophageal duodenogastroesophageal reflux exposure compared to groups B and C. Multivariate analysis identified the presence of esophagitis and pathological distal esophageal acid exposure as risk factors for the need of maintenance therapy. In patients with reflux-related ENT symptoms, initial findings on upper GI endoscopy and 24-hr pH-metry help to predict the need for maintenance therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Richter JE: Typical and atypical manifestations of gastroesophageal reflux disease. Gastroenterol Clin North Am 25:75–102, 1996

    Article  CAS  PubMed  Google Scholar 

  2. Sataloff RT, Castell DO, Katz PO, Sataloff DM: Reflux Laryngitis and Related Disorders. San Diego, CA, Singular, 1999

    Google Scholar 

  3. Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease. Laryngoscope 101 (Suppl 53):1–78, 1991

    CAS  PubMed  Google Scholar 

  4. Kamel PL, Hanson DG, Kahrilas PJ: Omeprazole for the treatment of posterior laryngitis. Am J Med 321–326, 1994

  5. Hanson DG, Kamel PL, Kahrilas PJ: Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 104:550–555, 1995

    CAS  PubMed  Google Scholar 

  6. Jaspersen D, Weber R, Hammar CH, Draf W: Effect of omeprazole on the course of associated esophagitis and laryngitis. J Gastroenterol 31: 765–767, 1996

    CAS  PubMed  Google Scholar 

  7. Loughlin CJ, Koufman JA: Paroxysmal laryngospasm secondary to gastroesophageal reflux. Laryngoscope 106:1502–1505, 1996

    CAS  PubMed  Google Scholar 

  8. Cherry J, Margulies SI: Contact ulcer of the larynx. Laryngoscope 78:1937–1940, 1968

    CAS  PubMed  Google Scholar 

  9. Öhman L, Olofsson J, Tibbling L, Ericsson G: Esophageal dysfunction in patients with contact ulcer of the larynx. Ann Otol Rhinol Laryngol 92:228–230, 1983

    PubMed  Google Scholar 

  10. Ward PH, Zwitman D, Hanson D, Berci G: Contact ulcers and granulomas of the larynx: new insights into their etiology as a basis for more rational treatment. Otolaryngol Head Neck Surg 88:262–269, 1980

    CAS  PubMed  Google Scholar 

  11. Miko TL: Peptic (contact ulcer) granuloma of the larynx. J Clin Pathol 42:800–804, 1989

    CAS  PubMed  Google Scholar 

  12. Little FB, Koufman JA, Kohut RI, Marshall RB: Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 94:516–519, 1985

    CAS  PubMed  Google Scholar 

  13. Ward PH, Hanson DG: Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 98:1195–1199, 1988

    CAS  PubMed  Google Scholar 

  14. Ward PH, Bercy G: Observations on the pathogenesis of chronic non-specific pharyngitis and laryngitis. Laryngoscope 92:1377–1382, 1982

    CAS  PubMed  Google Scholar 

  15. Bothwell MR, Parsons DS, Talbot A, Barbero GJ, Wilder B: Outcome of reflux therapy on pediatric chronic sinusitis. Otolaryngol Head Neck Surg 121:255–262, 1999

    Article  CAS  PubMed  Google Scholar 

  16. Ulualp SO, Toohill RJ, Hoffman R, Shaker R: Possible relationship of gastroesophagolaryngeal reflux with pathogenesis of chronic sinusitis. Am J Rhinol 13:197–202, 1999

    CAS  PubMed  Google Scholar 

  17. Phipps CD, Wood WE, Gibson WS, Cochran WJ: Gastroesophageal reflux contributing to chronic sinus disease in children. A prospective analysis. Arch Otolaryngol Head Neck Surg 126:831–836, 2000

    CAS  Google Scholar 

  18. DiBaise JK, Huerter JV, Quigley EMM: Sinusitis and gastroesophageal reflux disease. Ann Intern Med 129:1078, 1998

    CAS  PubMed  Google Scholar 

  19. DiBaise JK, Bolarinwa F. Olusola, Huerter JV, Quigley EMM: Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial. Am J Gastroenterol 97:843–849, 2002

    PubMed  Google Scholar 

  20. Tasker A, Dettmar PW, Panetti M, Koufman JA, Birchall JP, Pearson JP: Reflux of gastric juice and glue ear in children. Lancet 359:493, 2002

    Article  PubMed  Google Scholar 

  21. Poelmans J, Tack J, Feenstra L: Chronic middle ear disease and gastroesophageal reflux disease: A causal relation? Otol Neurotol 22:447–450, 2001

    CAS  PubMed  Google Scholar 

  22. Poelmans J, Tack J, Feenstra L: Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy. Ann Otol Rhinol Laryngol 111:933–938, 2002

    PubMed  Google Scholar 

  23. Poelmans J, Feenstra L, Tack J, Demedts I, Rutgeerts P: The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose and throat symptoms. Am J Gastroenterol 99:1419–1426, 2004

    Article  PubMed  Google Scholar 

  24. Poelmans J, Feenstra L, Tack J: The role of (duodeno) gastroesophagealreflux in unexplained excessive throat phlegm. Dig Dis Sci 50:824–832, 2004

    Google Scholar 

  25. Poelmans J, Feenstra L, Tack J: Paroxysmal laryngospasm: A typical but underrecognised supraesophageal manifestation of gastroesophageal reflux? Dig Dis Sci 49:1868–1874, 2005

    Google Scholar 

  26. Ossakow SJ, Elta G, Bogdasarian R, Colturi T, Nostrant TT: Esophageal reflux and dysmotility as the basis for persistent cervical symptoms. Ann Otol Rhinol Laryngol 96:387–392, 1987

    CAS  PubMed  Google Scholar 

  27. Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA: Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 100:395–405, 1996

    Article  CAS  PubMed  Google Scholar 

  28. Schnatz PF, Castell JA, Castell DO: Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and direct therapy. Am J Gastroenterol 91:1715–1718, 1996

    CAS  PubMed  Google Scholar 

  29. Ollyo JB, Lang F, FonttollietC, Monnier P: Savary-Miller's new endoscopic grading of reflux-esophagitis: a simple, reproducible, logical, complete and useful classification. Gastroenterology 98:A100, 1990

    Google Scholar 

  30. Tack J, Bisschops R, Koek GH, Sifrim D, Lerut T, Janssens J: Dietary restrictions during ambulatory monitoring of duodeno-gastro-esophageal reflux. Dig Dis Sci 48:1213–1220, 2003

    CAS  PubMed  Google Scholar 

  31. Cool M, Poelmans J, Feenstra L, Tack J: Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroeenterol. 99:2317–2323, 2004

    Google Scholar 

  32. El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM: Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 96(4):979–983, 2001

    Article  CAS  PubMed  Google Scholar 

  33. Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, Levine PA: Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 111(12):2147–2151, 2001

    CAS  PubMed  Google Scholar 

  34. Caro JJ, Salas M, Ward A: Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton pump inhibitors lansoprazole, rabeprazole and pantoprazole, compard with omeprazole, ranitidine and placebo: evidence from randomised clinical trials. Clin Ther 23:998–017, 2001

    Article  CAS  PubMed  Google Scholar 

  35. Poelmans J, Degreef T, Feenstra L, Tack J: Esophageal sensorimotor function in patients with suspected reflux-related chronic ear, nose and throat symptoms. submitted for publication

  36. Ormseth EJ, Wong RKH: Reflux laryngitis: pathophysiology, diagnosis and management. Am J Gastroenterol 94:2812–2817, 1999

    Article  CAS  PubMed  Google Scholar 

  37. Vaezi MF, Richter JE: Duodenogastroesophageal reflux and methods to monitor nonacidic reflux. Am J Med 111 (Suppl 8A):160S–168S, 2001

    PubMed  Google Scholar 

  38. Tack J, Koek G, Demedts I, Sifrim D, Janssens J: Gastroesophageal reflux disease poorly responsive to single dose proton pump inhibitors: acid reflux, bile reflux or both, Am J Gastroenterol 99:981–988, 2004

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium

    Johan Poelmans PhD, MD & Louw Feenstra PhD, MD

  2. Department of Medicine, Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium

    Jan Tack PhD, MD

  3. Center for Gastroenterological Research, Catholic University of Leuven, Herestraat 49, B-3000, Leuven, Belgium

    Jan Tack PhD, MD

Authors
  1. Johan Poelmans PhD, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louw Feenstra PhD, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan Tack PhD, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Tack PhD, MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poelmans, J., Feenstra, L. & Tack, J. Determinants of Long-Term Outcome of Patients with Reflux-Related Ear, Nose, and Throat Symptoms. Dig Dis Sci 51, 282–288 (2006). https://doi.org/10.1007/s10620-006-3126-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-3126-y

Key Words

Search

Navigation